EPIC | OXB |
Sector | Pharma and Biotech |
ISIN | GB00BDFBVT43 |
Market Sector | MAIN |
Market Segment | SSMM |
Main Indices | techMARK, FTSE Small Cap, FTSE All-Share, FTSE techMARK Focus |
Country of register | Great Britain |
Currency | British Pound |
Market Cap | £436.93m |
NMS | 2,000 |
Shares in issue | 105.92m |
Date Listed | 17-Apr-2001 |
Currency | UK Pounds |
Share Price | 412.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 445.00 |
52 Week Low | 166.80 |
Volume | 127,284 |
Shares Issued | 105.92m |
Market Cap | £436.93m |
Beta | 1.21 |
RiskGrade | 125 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 3 |
Neutral | 5 |
Sell | 0 |
Strong Sell | 0 |
Total | 9 |
No dividends found |
Time | Volume / Share Price |
16:29 | 21 @ 413.50p |
16:29 | 444 @ 413.50p |
16:26 | 850 @ 412.60p |
16:21 | 42 @ 413.50p |
16:21 | 1,000 @ 413.00p |
Chair | Roch Doliveux |
CEO | Frank Mathias |
CFO | Lucinda (Lucy) Crabtree |
You are here: research